Able JA, Gudelsky GA, Vorhees CV, Williams MT (2006) 3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol Psychiatr 59(12):1219–1226. https://doi.org/10.1016/j.biopsych.2005.09.006

Affaitati A, Cardone L, De Cristofaro T et al (2003) Essential role of A-kinase anchor protein 121 for cAMP signaling to mitochondria. J Biol Chem 278(6):4286–4294

Alves E, Summavielle T, Alves CJ et al (2009) PRECLINICAL STUDY: Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A. Addict Biol 14(2):185–193

Arias-Cavieres A, Rozas C, Reyes-Parada M et al (2010) MDMA (“ecstasy”) impairs learning in the Morris Water Maze and reduces hippocampal LTP in young rats. Neurosci Lett 469(3):375–379. https://doi.org/10.1016/j.neulet.2009.12.031

Asl SS, Mousavizedeh K, Pourheydar B, Soleimani M, Rahbar E, Mehdizadeh M (2013) Protective effects of N-acetylcysteine on 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in male Sprague-Dawley rats. Metab Brain Dis 28(4):677–686

Azami K, Etminani M, Tabrizian K et al (2010) The quantitative evaluation of cholinergic markers in spatial memory improvement induced by nicotine–bucladesine combination in rats. Eur J Pharmacol 636(1–3):102–107

Barbosa DJ, Capela JP, Feio-Azevedo R, Teixeira-Gomes A, de Lourdes BM, Carvalho F (2015) Mitochondria: key players in the neurotoxic effects of amphetamines. Arch Toxicol 89(10):1695–1725

Barrett SP, Darredeau C, Pihl RO (2006) Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol Clin Exp 21(4):255–263

Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA (2009) Effects of dose and route of administration on pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine in the rat. Drug Metab Dispos 37(11):2163–2170

Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72(1–2):248–254

Brunt TM, Koeter MW, Niesink RJ, van den Brink W (2012) Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology 220(4):751–762

Cai X, Gu Z, Zhong P, Ren Y, Yan Z (2002) Serotonin 5-HT1A receptors regulate AMPA receptor channels through inhibiting Ca2+/calmodulin-dependent kinase II in prefrontal cortical pyramidal neurons. J Biol Chem 277(39):36553–36562

Capela J, Macedo C, Branco P et al (2007) Neurotoxicity mechanisms of thioether ecstasy metabolites. Neuroscience 146(4):1743–1757

Chu T, Kumagai Y, DiStefano EW, Cho AK (1996) Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem Pharmacol 51(6):789–796

Concheiro M, Baumann MH, Scheidweiler KB, Rothman RB, Marrone GF, Huestis MA (2014) Nonlinear pharmacokinetics of (±)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat. Drug Metab Dispos 42(1):119–125

Crawford CA, Williams MT, Kohutek JL et al (2006) Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35 S] GTPγS binding in adult rats. Brain Res 1077(1):178–186

D’Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Rev 36(1):60–90

D'Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36(1):60–90

Degenhardt L, Coffey C, Carlin JB, Moran P, Patton GC (2007) Who are the new amphetamine users? A 10-year prospective study of young Australians. Addiction (Abingdon, England) 102(8):1269–1279. https://doi.org/10.1111/j.1360-0443.2007.01906.x

Delaforge M, Jaouen M, Bouille G (1999) Inhibitory metabolite complex formation of methylenedioxymethamphetamine with rat and human cytochrome P450. Particular involvement of CYP 2D. Environ Toxicol Pharmacol 7(3):153–158

Eftekharzadeh B, Ramin M, Khodagholi F et al (2012) Inhibition of PKA attenuates memory deficits induced by beta-amyloid (1–42), and decreases oxidative stress and NF-kappaB transcription factors. Behav Brain Res 226(1):301–308. https://doi.org/10.1016/j.bbr.2011.08.015

Eskandari MR, Fard JK, Hosseini M-J, Pourahmad J (2012) Glutathione mediated reductive activation and mitochondrial dysfunction play key roles in lithium induced oxidative stress and cytotoxicity in liver. Biometals 25(5):863–873

Esteban B, O'Shea E, Camarero J, Sanchez V, Green AR, Colado MI (2001) 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154(3):251–260

Farre M, De La Torre R, Mathúna BÓ et al (2004) Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology 173(3–4):364–375

Ghazi-Khansari M, Mohammadi-Bardbori A, Hosseini MJ (2006) Using Janus green B to study paraquat toxicity in rat liver mitochondria: role of ACE inhibitors (thiol and nonthiol ACEi). Ann N Y Acad Sci 1090(1):98–107

Hall H, Lundkvist C, Halldin C et al (1997) Autoradiographic localization of 5-HT 1A receptors in the post-mortem human brain using [3 H] WAY-100635 and [11 C] WAY-100635. Brain Res 745(1):96–108

Heydari A, Yeo KR, Lennard M, Ellis SW, Tucker G, Rostami-Hodjegan A (2004) Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine. Drug Metab Dispos 32(11):1213–1217

Jamali B, Ardakani YH, Foroumadi A, Kobarfard F, Rouini MR (2013) Determination of MDMA and its three metabolites in the rat perfused liver. J Anal Toxicol 37(6):357–361. https://doi.org/10.1093/jat/bkt039

Johansen P, Krebs T (2009) How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale. J Psychopharmacol 23(4):389–391

Karuppagounder SS, Bhattacharya D, Ahuja M et al (2014) Elucidating the neurotoxic effects of MDMA and its analogs. Life Sci 101(1–2):37–42. https://doi.org/10.1016/j.lfs.2014.02.010

Kiyatkin EA, Kim AH, Wakabayashi KT, Baumann MH, Shaham Y (2014) Critical role of peripheral vasoconstriction in fatal brain hyperthermia induced by MDMA (Ecstasy) under conditions that mimic human drug use. J Neurosci 34:7754–7762

Lyles J, Cadet JL (2003) Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res Rev 42(2):155–168

Meyer JS, Piper BJ, Vancollie VE (2008) Development and characterization of a novel animal model of intermittent MDMA (“Ecstasy”) exposure during adolescence. Ann N Y Acad Sci 1139(1):151–163

Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R (2011) The safety and efficacy of±3, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol 25(4):439–452

Moyano S, Del Rio J, Frechilla D (2004) Role of Hippocampal CaMKII in serotonin 5-HTIA receptor-mediated learning deficit in rats. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 29(12):2216–2224

Mueller M, Peters FT, Maurer HH, McCann UD, Ricaurte GA (2008) Nonlinear pharmacokinetics of (±) 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses. J Pharmacol Exp Ther 327(1):38–44

Mueller M, Yuan J, Felim A et al (2009) Further studies on the role of metabolites in (±)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity. Drug Metab Dispos 37(10):2079–2086

Mueller M, Goodwin AK, Ator NA, McCann UD, Ricaurte GA (2011) Metabolism and disposition of 3,4-methylenedioxymethamphetamine (“ecstasy”) in baboons after oral administration: comparison with humans reveals marked differences. J Pharmacol Exp Ther 338(1):310–317

Nassireslami E, Nikbin P, Payandemehr B et al (2013) A cAMP analog reverses contextual and tone memory deficits induced by a PKA inhibitor in Pavlovian fear conditioning. Pharmacol Biochem Behav 105:177–182

Nguyen P, Woo N (2003) Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Prog Neurobiol 71(6):401–437

Papa S, De Rasmo D, Technikova-Dobrova Z et al (2012) Respiratory chain complex I, a main regulatory target of the cAMP/PKA pathway is defective in different human diseases. FEBS Lett 586(5):568–577

Pazos A, Palacios J (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346(2):205–230

Pizarro N, de la Torre R, Farre M, Segura J, Llebaria A, Joglar J (2002) Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites. Bioorg Med Chem 10(4):1085–1092

Reneman L, Booij J, Schmand B, van den Brink W, Gunning B (2000) Memory disturbances in” Ecstasy” users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148(3):322–324

Rodríguez-Arias M, Maldonado C, Vidal-Infer A, Guerri C, Aguilar MA, Miñarro J (2011) Intermittent ethanol exposure increases long-lasting behavioral and neurochemical effects of MDMA in adolescent mice. Psychopharmacology 218(2):429–442

Ros-Simó C, Moscoso-Castro M, Ruiz-Medina J, Ros J, Valverde O (2013) Memory impairment and hippocampus specific protein oxidation induced by ethanol intake and 3,4-methylenedioxymethamphetamine (MDMA) in mice. J Neurochem 125(5):736–746

Schiapparelli L, Del Río J, Frechilla D (2005) Serotonin 5-HT1A receptor blockade enhances Ca2+/calmodulin-dependent protein kinase II function and membrane expression of AMPA receptor subunits in the rat hippocampus: implications for memory formation. J Neurochem 94(4):884–895

Shaki F, Hosseini M-J, Ghazi-Khansari M, Pourahmad J (2012) Toxicity of depleted uranium on isolated rat kidney mitochondria. Biochimica et Biophysica Acta (BBA) Gen Subj 1820(12):1940–1950

Shaki F, Hosseini M-J, Ghazi-Khansari M, Pourahmad J (2013) Depleted uranium induces disruption of energy homeostasis and oxidative stress in isolated rat brain mitochondria. Metallomics 5(6):736–744

Shi Y (2002) Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9(3):459–470

Sprague JE, Preston AS, Leifheit M, Woodside B (2003) Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol Behav 79(2):281–287

Starr MA, Page ME, Waterhouse BD (2008) MDMA (3,4-methylenedioxymethamphetamine)-mediated distortion of somatosensory signal transmission and neurotransmitter efflux in the ventral posterior medial thalamus. J Pharmacol Exp Ther 327(1):20–31

Upreti VV, Eddington ND (2008) Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat. J Pharm Sci 97(4):1593–1605

Valtier S, Phelix CF, Cody JT (2007) Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA. J Anal Toxicol 31(3):138–143